C
Cora N. Sternberg
Researcher at Cornell University
Publications - 747
Citations - 57991
Cora N. Sternberg is an academic researcher from Cornell University. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 92, co-authored 663 publications receiving 48986 citations. Previous affiliations of Cora N. Sternberg include CTO Hospital & North Shore University Hospital.
Papers
More filters
Journal Article
Phase II trial of idarubicin in patients with pancreatic cancer
Journal ArticleDOI
Tumor-immune microenvironment revealed by Imaging Mass Cytometry in a metastatic sarcomatoid urothelial carcinoma with a prolonged response to pembrolizumab
Hussein Alnajar,Hiranmayi Ravichandran,André Figueiredo Rendeiro,Kentaro Ohara,Wael Al Zoughbi,Jyothi Manohar,Noah Greco,Michael Sigouros,Jesse Fox,Emily Muth,Samuel V. Angiuoli,Bishoy Faltas,Michael Shusterman,Cora N. Sternberg,Olivier Elemento,Juan Miguel Mosquera +15 more
TL;DR: A novel case report of the first Imaging Mass Cytometry (IMC) analysis done in SUC is presented to investigate the immune cell repertoire and PD-L1 expression in a patient who presented with metastatic SUC and experienced a prolonged response to the anti-PD1 immune checkpoint inhibitor pembrolizumab after progression on first-line chemotherapy.
Journal ArticleDOI
1142 Neo-adjuvant M-VAC chemotherapy and bladder preservation for muscle infiltrating transitional cell carcinoma (TCC) of the bladder
Cora N. Sternberg,V. Pansadora,Stefano Lauretti,A. Platania,Diana Giannarelli,Antonella Rossetti,P. De Carli,A. Cancrini +7 more
TL;DR: Although bladder conservation is feasible in selected patients, they remain at risk for recurrence, and response to chemotherapy may be the most important predictor of survival.
Journal ArticleDOI
Real-world outcomes of second novel hormonal therapy or radium-223 following first novel hormonal therapy for mCRPC.
Oliver Sartor,Daniel J. George,Bertrand Tombal,Neeraj Agarwal,Celestia S. Higano,Cora N. Sternberg,Kurt Miller,XiaoLong Jiao,Helen Guo,Per Sandstrom,Amanda Bruno,Frank Verholen,Fred Saad,Neal D. Shore +13 more
TL;DR: In this paper, the authors evaluated real-world clinical outcomes of radium-223 or alternative novel hormonal therapy (NHT) following first-line NHT for metastatic castration-resistant prostate cancer (mCRPC).
Journal ArticleDOI
Mp52-19 impact of enzalutamide on pain and health-related quality of life in men with non-metastatic castration-resistant prostate cancer: prosper study results
Fred Saad,David F. Penson,Gerhardt Attard,Maha Hussain,Cora N. Sternberg,S Naidoo,Katharina Modelska,Eren Demirhan,Krishnan Ramaswamy,Konstantina Skaltsa,Bertrand Tombal +10 more